AzTrials
AzTrials

Hoarding DisorderNCT04712474

In-home Decluttering Augmentation of Group CBT for HD

A study testing In-home decluttering practice in people with Hoarding Disorder, run by Karolinska Institutet at 1 site in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The primary aim of trial is to determine the clinical efficacy of in-home decluttering augmentation of group CBT for reducing hoarding severity in adults with HD. The trial takes place in Sweden. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hoarding Disorder
What is being tested?
In-home decluttering practice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteSweden
Study dates
29 Jan 2021to 31 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older.
  • Hoarding disorder as primary psychiatric condition.
  • Willing and able to understand and complete consent and study procedures.
  • Living in the Stockholm county (Sweden) and within a 1-hour commute by public transport from the social services office.

Who cannot join

  • Concurrent CBT or having received CBT for HD during the last two years, for a minimum of 8 sessions including active strategies for reducing acquisition and practice of discarding with a qualified therapist or 8 previous in-home decluttering sessions with a qualified social worker.
  • Unable or unwilling to allow study staff into home for home assessment.
  • Animal hoarding or squalid (i.e. extremely unhygienic) home conditions that are deemed to put the personnel at risk during the in-home decluttering.
  • A diagnosis of organic brain disorder, intellectual disability, psychosis, bipolar disorder without stable medication or with symptoms within the last 6 months, anorexia nervosa or alcohol/substance dependence or abuse.
  • Major medical or neurological conditions that increase the risk of participation or that would prevent completing assigned behavioral practice tasks.
  • Immediate risk to self or others, requiring urgent medical attention, such as high suicidality risk.
Show all 9Show fewer
  • Participant not able to read and communicate in Swedish.
  • Currently at high risk for eviction (for instance having received a "rättelseanmaning" by the housing company or Swedish court).
  • Potential participant lives in the same household as an already included participant.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst Stockholm, Huddinge, Sweden, 141 86

    Stockholm, 141 86

Other trials in Sweden

About this study

Official title: In-home Decluttering Augmentation of Group Cognitive-behavior Therapy for Hoarding Disorder: The Joining Forces Randomized Controlled Trial

The primary aim of trial is to determine the clinical efficacy of in-home decluttering augmentation of group CBT for reducing hoarding severity in adults with HD. The trial takes place in Sweden.

Read the detailed description

Cognitive behavioral therapy (CBT) is the current evidence-based treatment for HD but the majority of sufferers remain symptomatic after CBT with impairing levels of clutter in their homes. Home visits, with a focus on in-home decluttering, have in previous research been shown to be a promising intervention when combined with CBT. However, augmenting CBT with subsequent home visits has not yet been tested in a randomized controlled trial (RCT). In response to this, in this trial, we aim to investigate the efficacy of a coordinated intervention, consisting of CBT and in-home decluttering for HD, in an RCT. In this trial, 90 participants with HD will initially receive 12 sessions of CBT through a psychiatric outpatient service. After CBT, participants will be randomized to receive either 10 home visits in 10 weeks, or to a wait list condition. Our hypothesis is that augmenting CBT with home visits will lead to a reduction in hoarding symptoms and clutter and improved daily functioning compared to wait list. We will also investigate the cost-economical aspects of the intervention. Results from this trial have the potential to reveal whether in-home decluttering should be added to CBT in order to reduce symptoms of hoarding and improve function in indviduals with HD.

Being tested
In-home decluttering practice
Keywords
hoarding, clutter
Medical subject headings
Hoarding Disorder, Hoarding, Speech Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In-home decluttering practiceBehavioural

    The in-home decluttering intervention comprises 10, 1.5-hour home-visits over the course of 10 weeks.

    These home visits are personalized, goal-oriented and focused on decluttering. They include 1) a brief check-in, 2) guided unclutter time 3) a reflective period during which participants share their thoughts and objectives for the coming week, and 4) homework assignments.

Study groups in NCT04712474
Study groupRoleWhat they receive
In-home declutteringExperimentalStudy participants receive weekly sessions of in-home decluttering for 10 weeks.
Receives: Behavioral: In-home decluttering practice
Delayed treatmentNo interventionStudy participants receive weekly session of in-home decluttering after a 10 week delay.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Saving Inventory-Revised (SI-R)

    The SI-R is a 23-item questionnaire with 3 sub-scales: 1) difficulty discarding, 2) excessive clutter, and 3) excessive acquisition.

    Measured: Change from baseline (week 0) to post-treatment (week 10),

  2. Clutter Image Rating Scale (CIR)

    Three sets of photographs, each comprising 9 photos of a room with varying levels of clutter. A selection is made as to which photograph best resembles the room of the participant.

    Measured: Change from baseline (week 0) to post-treatment (week 10).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2021
  2. Study start29 Jan 2021
  3. Primary completion27 Feb 2025
  4. Study completion31 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04712474
Sponsor's protocol ID
2020-05798
Status last verified
Sep 2025
First submitted
13 Jan 2021
Last updated
19 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Jagholm S, Lindstedt S, Andersson E, Mataix-Cols D, Fernandez de la Cruz L, Ruck C, Ivanov VZ. Study protocol for a randomized controlled trial of in-home decluttering augmentation of group cognitive-behavioral therapy for hoarding disorder: the Joining Forces Trial. Trials. 2023 Jul 29;24(1):483. doi: 10.1186/s13063-023-07509-4.

    PubMed 37507772

Questions about this trial

What is this clinical trial studying?

A study testing In-home decluttering practice in people with Hoarding Disorder, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Saving Inventory-Revised (SI-R) (time frame: Change from baseline (week 0) to post-treatment (week 10),). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04712474, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in